323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2021W)
Continuous assessment of course work
Labels
MIXED
Präsenz oder Hybrid oder Online, je nach Situation.
01.10.2021 13.15-16.00 Uhr HS 5
04.10.2021 13.15-16.30 Uhr HS 7
05.10.2021
06.10.2021
07.10.2021
08.10.2021
11.10.2021 14.00-17.00 Uhr 2D313
12.10.2021 14.00-17.00 Uhr 2D313
13.10.2021
14.10.2021 14.00-17.00 Uhr 2D313
15.10.2021 14.00-17.00 Uhr 2D313
18.10.2021 14.00-17.00 Uhr 2D313
19.10.2021 14.00-17.00 Uhr LAB
22.10.2021 13.15-16.30 Uhr HS 8
01.10.2021 13.15-16.00 Uhr HS 5
04.10.2021 13.15-16.30 Uhr HS 7
05.10.2021
06.10.2021
07.10.2021
08.10.2021
11.10.2021 14.00-17.00 Uhr 2D313
12.10.2021 14.00-17.00 Uhr 2D313
13.10.2021
14.10.2021 14.00-17.00 Uhr 2D313
15.10.2021 14.00-17.00 Uhr 2D313
18.10.2021 14.00-17.00 Uhr 2D313
19.10.2021 14.00-17.00 Uhr LAB
22.10.2021 13.15-16.30 Uhr HS 8
Details
Language: English
Lecturers
Classes (iCal) - next class is marked with N
- Friday 01.10. 13:15 - 17:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
- Monday 04.10. 13:15 - 16:30 UZA2 Hörsaal 7 (Raum 2Z210) 2.OG
- Tuesday 05.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 06.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Thursday 07.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
-
Friday
08.10.
14:00 - 17:00
Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
UZA2 Hörsaal 4 (Raum 2Z221) 2.OG - Monday 11.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Tuesday 12.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Wednesday 13.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Thursday 14.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 15.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Monday 18.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Friday 22.10. 13:15 - 16:30 UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
Information
Aims, contents and method of the course
The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.
Assessment and permitted materials
There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the material collected during the class and the studies for the class.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the material collected during the class and the studies for the class.
Minimum requirements and assessment criteria
The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.
Examination topics
All topics covered during the course.
Reading list
Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)
Association in the course directory
Last modified: Fr 01.04.2022 09:09